Pharmafile Logo
Pharmafocus logo
Advanced Search

Aventis’ Apidra approved in US

April 26, 2004

The FDA has approved Aventis' rapid-acting insulin analogue Apidra, ahead of an anticipated August approval by the EMEA, as the …

News

No change one year on from NSF, says diabetes charity

April 26, 2004

One year on from the launch of the National Service Framework (NSF) for Diabetes, the planning of care has improved …

News

Wyeth’s Zoton hot on the heels of over-the-counter Zanprol

April 26, 2004

Wyeth, manufacturers of the UK's biggest selling prescription drug Zoton plan to take the drug POM-P, hot on the heels …

News

The brave new GMS world

April 26, 2004

The new General Medical Services contract (nGMS) started officially on 1st April, though its far-reaching effects may be far from …

Feature

Supporting the everyday experts

April 26, 2004

We are all familiar with the growth of the ageing population during the second half of the 20th century and …

Feature

Targeting the new prescribers

April 26, 2004

Feature

Sanofi slims down portfolio in preparation for Aventis acquisition

April 15, 2004

Sanofi-Synthelabo has agreed to sell two of its products to GlaxoSmithKline, as it seeks to avoid potential problems with competition …

News

Britannia and Otsuka collaborate on autoimmune disease treatment

April 15, 2004

Britannia Pharmaceuticals has entered into an agreement with Otsuka Pharmaceuticals UK to manage the UK distribution of the novel treatment …

News

Heart concerns halt Acambis trials

April 15, 2004

UK biotech Acambis has suspended Phase III clinical trials of its smallpox vaccine after three patients suffered a heart inflammation …

News

Humira gives Abbott a shot in the arm

April 15, 2004

News

Avastin gets off to a flying start

April 15, 2004

US biotech Genentech's first quarter results have surpassed estimates as the company posted profit growth of 17% to $176.6 million, …

News

Merck and S-P’s cholesterol combination approved in Germany

April 15, 2004

News

Giving patients more choice

April 15, 2004

You might be forgiven for having missed the launch of Labour's new policy statement on patient choice, Building on the …

Feature

Aventis invites Novartis ‘white knight’ bid

April 7, 2004

Aventis has formally invited Swiss rival Novartis into merger talks, but still needs to convince the French government of the …

News

Lilly’s ‘Le Weekender’ gaining ground on Viagra

April 7, 2004

Eli Lilly's Cialis is rapidly winning market share from Viagra, Pfizer's trailblazing erectile dysfunction (ED) drug, which is now starting …

News

Another April revolution to transform the NHS

April 7, 2004

For the second time in three years, the National Health Service has undergone an April revolution through the major re-engineering …

News

Crestor hits ‘a bump in the road’ as BMS study backfires

April 6, 2004

AstraZeneca's Crestor has suffered a setback in the US as its share in the highly competitive statin market fell back …

News

Medical magazines most useful form of communication, say GPs

April 6, 2004

A new survey of GPs shows they find medical publications to be the most useful of all media – results …

News

Contract underway but GPs gloomy about the future of health service

April 6, 2004

The long-awaited new General Medical Services contract has arrived, with the majority of general practices in the UK now working …

News

New ‘harmonising’ NHS watchdog begins work

April 6, 2004

'Inspecting, informing, improving' is the motto of the new watchdog for both the NHS and private healthcare facilities.

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025